Lonza has completed an expansion at its API manufacturing site at Nansha, China, as part of its recent investment to expand mid-scale capacity there. This focused on extending the capabilities and capacity of development laboratories and kilo-scale cGMP manufacturing laboratories for clinical supply of HPAPIs.

Waste2Func, a European BBI-JU funded project, has been granted €6.7 million to build a technology platform. This will collect food waste from agriculture, food manufacturing, supermarkets, auctions and restaurants, and convert it via fermentation and purification into lactic acid and biosurfactants with applications in cosmetics, personal care and household care products. The project began in June 2021 and will end in November 2024, with a total budget of €13.965 million.

Sinocompound Catalysts, a supplier of advanced homogeneous catalysts and ligands based in Zhangjiagang, China, has announced production of QPhos in kilogram quantities. Hitherto, the company said, its use in process development and scale-up has been hindered by the lack of commercial-scale capacity, despite its huge potential.

Brenntag has entered the Israeli market by acquiring distributor Y.S. Ashkenazi Agencies and its subsidiary Biochem Trading. The firm is the said to be the national market leader in personal care, and food and nutrition as well as one of the largest speciality chemical distributors. Terms were not disclosed and the deal has already been completed.

CDMO Sterling Pharma Solutions has agreed to acquire Novartis’s 45-hectare Ringaskiddy campus near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed. All of the workforce will transfer to Sterling, bringing its global total to over 1,000.

The deal also includes an ongoing supply agreement for products Novartis has made at the site. The facilities include three API manufacturing buildings, plus facilities to support development and scale-up.  

The board and shareholders of Hovione have named Dr Jean-Luc Herbeaux (right) as CEO from 1 April. He had originally joined the firm as COO in May 2020, after multiple leadership positions at Evonik, where he last headed the Health Care business line.

BASF is building a new world-scale plant for alkylethanolamines at the verbund site in Antwerp, Belgium, one of four sites where it already producest them. This will increase the firm’s global capacity by nearly 30% to 140,000 tonnes/year. Start-up is planned for 2024